M Miles Braun
Biographic Data
| ID | 5542744 |
|---|---|
| NAME | M Miles Braun |
| GIVEN NAMES | M Miles |
| FAMILY NAME | Braun |
| SIGNATURE | BRAUN M M |
| AFFILIATIONS | Center for Biologics Evaluation and Research |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 2 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2004 |
| LATEST PUBLICATION YEAR | 2009 |
| H-INDEX | 1 |
What Should an Ideal Vaccine Postlicensure Safety System Be
In 2007 the National Vaccine Program, along with the Centers for Disease Control and Prevention, the Food and Drug Administration, the National Institutes of Health, and the Health Resources and Services Administration, sponsored a public conference titled “Vaccine Safety Evaluation: Post Marketing Surveillance.” The objective was to discuss enhanced approaches to postlicensure evaluation of vaccine safety, including active and passive surveillan…
Active Influenza Vaccine Safety Surveillance
BACKGROUND: Rapid safety assessment of novel vaccines, especially those targeted against pandemic influenza, is a public health priority. OBJECTIVES: Assess the feasibility of using healthcare claims data to rapidly detect influenza vaccine adverse events using sequential analytic methods. RESEARCH DESIGN: Retrospective pilot study simulating prospective surveillance using 6 cumulative monthly administrative claims data extracts. The first includ…
Vaccine Risk Perception Among Reporters of Autism After Vaccination
Objectives. We investigated vaccine risk perception among reporters of autism to the Vaccine Adverse Event Reporting System (VAERS). Methods. We conducted structured interviews with 124 parents who reported autism and related disorders to VAERS from 1990 to 2001 and compared results with those of a published survey of parents in the general population. Results. Respondents perceived vaccine-preventable diseases as less serious than did other pare…
What Should an Ideal Vaccine Postlicensure Safety System Be
In 2007 the National Vaccine Program, along with the Centers for Disease Control and Prevention, the Food and Drug Administration, the National Institutes of Health, and the Health Resources and Services Administration, sponsored a public conference titled “Vaccine Safety Evaluation: Post Marketing Surveillance.” The objective was to discuss enhanced approaches to postlicensure evaluation of vaccine safety, including active and passive surveillan…
Vaccine Risk Perception Among Reporters of Autism After Vaccination
Objectives. We investigated vaccine risk perception among reporters of autism to the Vaccine Adverse Event Reporting System (VAERS). Methods. We conducted structured interviews with 124 parents who reported autism and related disorders to VAERS from 1990 to 2001 and compared results with those of a published survey of parents in the general population. Results. Respondents perceived vaccine-preventable diseases as less serious than did other pare…
Vaccine Risk Perception Among Reporters of Autism After Vaccination
Objectives. We investigated vaccine risk perception among reporters of autism to the Vaccine Adverse Event Reporting System (VAERS). Methods. We conducted structured interviews with 124 parents who reported autism and related disorders to VAERS from 1990 to 2001 and compared results with those of a published survey of parents in the general population. Results. Respondents perceived vaccine-preventable diseases as less serious than did other pare…
What Should an Ideal Vaccine Postlicensure Safety System Be
In 2007 the National Vaccine Program, along with the Centers for Disease Control and Prevention, the Food and Drug Administration, the National Institutes of Health, and the Health Resources and Services Administration, sponsored a public conference titled “Vaccine Safety Evaluation: Post Marketing Surveillance.” The objective was to discuss enhanced approaches to postlicensure evaluation of vaccine safety, including active and passive surveillan…
Active Influenza Vaccine Safety Surveillance
BACKGROUND: Rapid safety assessment of novel vaccines, especially those targeted against pandemic influenza, is a public health priority. OBJECTIVES: Assess the feasibility of using healthcare claims data to rapidly detect influenza vaccine adverse events using sequential analytic methods. RESEARCH DESIGN: Retrospective pilot study simulating prospective surveillance using 6 cumulative monthly administrative claims data extracts. The first includ…
Influenza Virus Research Studies (3 works) · Medicine (3 works) · Vaccination (3 works) · Adverse effect (2 works) · Environmental health (2 works) · Family medicine (2 works) · Immunization (2 works) · Immunology (2 works) · Immunology (2 works) · Vaccine Coverage and Hesitancy (2 works)